+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lipid Nanoparticles Market by Source, Type, Method Of Preparation, Formulation, Size Range, functionality, Applications, End-User Industry - Global Forecast to 2030- Product Image
Lipid Nanoparticles Market by Source, Type, Method Of Preparation, Formulation, Size Range, functionality, Applications, End-User Industry - Global Forecast to 2030- Product Image
Sale

Lipid Nanoparticles Market by Source, Type, Method Of Preparation, Formulation, Size Range, functionality, Applications, End-User Industry - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016123
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Lipid Nanoparticles Market is undergoing rapid evolution as a central enabler of next-generation drug delivery, gene therapies, and advanced vaccines. This transformative segment is capturing significant attention from pharmaceutical leaders, biotech innovators, and investment decision-makers due to continual technology advancements and regulatory shifts.

Market Snapshot: Lipid Nanoparticles Market Growth Trajectory

The lipid nanoparticles market grew from USD 854.13 million in 2024 to USD 903.41 million in 2025, with expectations to reach USD 1.19 billion by 2030 at a CAGR of 5.82%. Sustained demand for targeted delivery and precision therapies, coupled with the mainstreaming of mRNA technologies and multifaceted applications across health, food, and personal care, are driving expansion across all key regions and verticals. This continued growth reflects the market’s agility in responding to shifts in global pharmaceutical, research, and supply chain needs.

Scope & Segmentation of the Lipid Nanoparticles Market

This report offers a comprehensive analysis of market structure, technological developments, and regional dynamics. Strategic segmentation provides clarity on opportunities across the value chain, including technologies and industry applications:

  • Source: Natural lipid nanoparticles; synthetic lipid nanoparticles
  • Type: Anionic, cationic, ionizable, neutral, PEGylated lipid nanoparticles
  • Preparation Methods: Emulsification-solvent evaporation, high-pressure homogenization, microfluidics, single-step nanoprecipitation, solvent injection method
  • Formulation: Nanostructured lipid carriers; solid lipid nanoparticles
  • Size Range: Less than 100nm, 100nm–200nm, more than 200nm
  • Functionality: Controlled release, enhanced bioavailability, targeted delivery
  • Application: Diagnostic imaging, drug delivery (anticancer drugs, gene therapy products, vaccines), nutrient encapsulation for food fortification, personal care
  • End-User Industry: Academic and research centers, biotechnology companies and institutes, pharmaceutical companies
  • Regional Coverage: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with key markets such as UK, Germany, France, and the UAE), Asia-Pacific (such as China, India, Japan, and others)
  • Company Analysis: Profiles on leading stakeholders including Acuitas Therapeutics Inc., Alnylam Pharmaceuticals, Arcturus Therapeutics, BioNTech SE, Moderna Inc., Pfizer Inc., Wacker Chemie AG, and additional players shaping the ecosystem

Key Takeaways for Strategic Decision Makers

  • The validation of ionizable lipid chemistries by mRNA vaccines has expanded adoption, enabling new modalities beyond traditional encapsulated drugs.
  • Microfluidic and nanoprecipitation technologies streamline manufacturing, enhancing product consistency and reducing time to market for clinical and commercial deployment.
  • Ongoing sustainability mandates drive adoption of eco-friendly lipid sources and bio-based surfactants, opening opportunities for brand differentiation and regulatory alignment.
  • The partnership model between gene therapy innovators and ingredient suppliers accelerates pipeline progress and ensures rapid scale-up of next-generation therapies.
  • Digital twins and machine learning are being adopted to optimize formulation development, lowering experimental attrition and enhancing regulatory readiness.
  • Regional specialization, from the biotech hubs of the Americas to scalable production in Asia-Pacific, supports global market resilience and advances technology transfer.

Tariff Impact: Navigating US Policy Changes

Recent US tariffs on excipients and lipid raw materials have disrupted traditional sourcing, increasing costs and impacting supply chain strategies. Stakeholders are investing in domestic production and considering just-in-time inventory models to mitigate risk. Additional regulatory burdens include more complex customs and licensing requirements, directly affecting procurement and project timelines. Cross-functional efforts with trade advisors are essential to access tariff exemptions, highlighting the strategic necessity of a diversified sourcing approach.

Methodology & Data Sources in Lipid Nanoparticles Research

This report synthesizes primary insights from interviews with executives, regulatory specialists, and technical leaders, complemented by secondary research covering patents, scientific literature, and corporate filings. Quantitative data is triangulated across shipment records, clinical trial entries, and trade statistics, with all assumptions validated by external expert workshops for precision and reliability.

Why This Report Matters to Senior Decision Makers

  • Gain precise strategic direction on segment prioritization, technology adoption pathways, and partnership opportunities within the lipid nanoparticles market.
  • Benchmark competitive positioning by leveraging profiles and recent developments from industry leaders and emerging innovators across the value chain.
  • Anticipate regulatory and market shifts, empowering proactive risk mitigation and long-term portfolio resilience.

Conclusion

As innovation and regulation reshape the lipid nanoparticles landscape, leaders equipped with targeted, actionable insights will capture emerging opportunities and steer organizational growth. This report enables your teams to navigate complexity, build robust strategies, and advance value creation across a rapidly evolving global market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lipid Nanoparticles Market, by Source
8.1. Introduction
8.2. Natural Lipid Nanoparticles
8.3. Synthetic Lipid Nanoparticles
9. Lipid Nanoparticles Market, by Type
9.1. Introduction
9.2. Anionic Lipid Nanoparticles
9.3. Cationic Lipid Nanoparticles
9.4. Ionizable Lipid Nanoparticles
9.5. Neutral Lipid Nanoparticles
9.6. PEGylated Lipid Nanoparticles
10. Lipid Nanoparticles Market, by Method Of Preparation
10.1. Introduction
10.2. Emulsification-Solvent Evaporation
10.3. High-Pressure Homogenization
10.4. Microfluidics
10.5. Single-Step Nanoprecipitation
10.6. Solvent Injection Method
11. Lipid Nanoparticles Market, by Formulation
11.1. Introduction
11.2. Nanostructured Lipid Carriers
11.3. Solid Lipid Nanoparticles
12. Lipid Nanoparticles Market, by Size Range
12.1. Introduction
12.2. 100nm - 200nm
12.3. Less Than 100nm
12.4. More Than 200nm
13. Lipid Nanoparticles Market, by functionality
13.1. Introduction
13.2. Controlled Release
13.3. Enhanced Bioavailability
13.4. Targeted Delivery
14. Lipid Nanoparticles Market, by Applications
14.1. Introduction
14.2. Diagnostic Imaging
14.3. Drug Delivery
14.3.1. Anticancer Drugs
14.3.2. Gene Therapy Products
14.3.3. Vaccines
14.4. Nutrient Encapsulation & Food Fortification
14.5. Personal Care
15. Lipid Nanoparticles Market, by End-User Industry
15.1. Introduction
15.2. Academic & Research Centers
15.3. Biotechnology Companies & Institutes
15.4. Pharmaceutical Companies
16. Americas Lipid Nanoparticles Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Lipid Nanoparticles Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Lipid Nanoparticles Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Acuitas Therapeutics Inc.
19.3.2. Alnylam Pharmaceuticals, Inc.
19.3.3. Arcturus Therapeutics Holdings Inc. by Alcobra Ltd.
19.3.4. Avanti Polar Lipids, LLC by Croda International Plc
19.3.5. BioNTech SE
19.3.6. Corden Pharma International GmbH
19.3.7. CureVac SE
19.3.8. Danaher Corporation
19.3.9. Entos Pharmaceuticals
19.3.10. Etherna Immunotherapies Nv
19.3.11. Evonik Industries AG
19.3.12. FUJIFILM Holdings Corporation
19.3.13. Generation Bio Co.
19.3.14. Genevant Sciences Corporation
19.3.15. GlaxoSmithKline PLC
19.3.16. GreenLight Biosciences, Inc.
19.3.17. Merck KGaA
19.3.18. METiS Pharmaceuticals
19.3.19. Moderna Inc.
19.3.20. Nitto Denko Corporation
19.3.21. Pfizer Inc.
19.3.22. Polymun Scientific Immunbiologische Forschung GmbH
19.3.23. RiboPro
19.3.24. Silence Therapeutics PLC
19.3.25. Translate Bio Inc by Sanofi S.A.
19.3.26. VBI Vaccines Inc.
19.3.27. Wacker Chemie AG
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. LIPID NANOPARTICLES MARKET MULTI-CURRENCY
FIGURE 2. LIPID NANOPARTICLES MARKET MULTI-LANGUAGE
FIGURE 3. LIPID NANOPARTICLES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL LIPID NANOPARTICLES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2030 (%)
FIGURE 22. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. LIPID NANOPARTICLES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. LIPID NANOPARTICLES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. LIPID NANOPARTICLES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIPID NANOPARTICLES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NATURAL LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SYNTHETIC LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ANIONIC LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY CATIONIC LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY IONIZABLE LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NEUTRAL LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY PEGYLATED LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY EMULSIFICATION-SOLVENT EVAPORATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY HIGH-PRESSURE HOMOGENIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SINGLE-STEP NANOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOLVENT INJECTION METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NANOSTRUCTURED LIPID CARRIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOLID LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY 100NM - 200NM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY LESS THAN 100NM, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY MORE THAN 200NM, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ENHANCED BIOAVAILABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ANTICANCER DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NUTRIENT ENCAPSULATION & FOOD FORTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. CANADA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 66. CANADA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 70. CANADA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 71. CANADA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 72. CANADA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 73. CANADA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 74. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 80. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 82. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 120. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 126. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 127. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 128. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 129. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 132. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 133. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 135. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 136. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 137. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 147. ITALY LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 148. ITALY LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. ITALY LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 150. ITALY LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 151. ITALY LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 152. ITALY LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 153. ITALY LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 154. ITALY LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 155. ITALY LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 156. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 157. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 159. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 160. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 161. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 162. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 163. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 164. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 192. DENMARK LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 193. DENMARK LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. DENMARK LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 195. DENMARK LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 196. DENMARK LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 197. DENMARK LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 198. DENMARK LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 199. DENMARK LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 200. DENMARK LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 210. QATAR LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 211. QATAR LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. QATAR LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 213. QATAR LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 214. QATAR LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 215. QATAR LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 216. QATAR LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 217. QATAR LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 218. QATAR LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 219. FINLAND LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 220. FINLAND LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. FINLAND LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 222. FINLAND LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 223. FINLAND LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 224. FINLAND LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 225. FINLAND LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 226. FINLAND LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 227. FINLAND LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 246. EGYPT LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 247. EGYPT LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. EGYPT LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 249. EGYPT LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 250. EGYPT LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 251. EGYPT LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 252. EGYPT LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 253. EGYPT LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 254. EGYPT LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 255. TURKEY LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 256. TURKEY LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. TURKEY LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 258. TURKEY LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 259. TURKEY LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 261. TURKEY LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 262. TURKEY LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 263. TURKEY LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 273. NORWAY LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 274. NORWAY LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. NORWAY LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 276. NORWAY LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. NORWAY LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 279. NORWAY LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 280. NORWAY LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 281. NORWAY LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 282. POLAND LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 283. POLAND LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 284. POLAND LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 285. POLAND LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 286. POLAND LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 287. POLAND LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 288. POLAND LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 289. POLAND LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 290. POLAND LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 310. CHINA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 311. CHINA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 312. CHINA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 313. CHINA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 314. CHINA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 315. CHINA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 316. CHINA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 317. CHINA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 318. CHINA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 319. INDIA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 320. INDIA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 321. INDIA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 322. INDIA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 323. INDIA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 324. INDIA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 325. INDIA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 326. INDIA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 327. INDIA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 328. JAPAN LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 329. JAPAN LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 330. JAPAN LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 331. JAPAN LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 332. JAPAN LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 333. JAPAN LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 334. JAPAN LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 335. JAPAN LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 336. JAPAN LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2030 (USD MILLION)
TABLE 342. AUSTRALIA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 343. AUSTRALIA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 344. AUSTR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Lipid Nanoparticles market report include:
  • Acuitas Therapeutics Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Arcturus Therapeutics Holdings Inc. by Alcobra Ltd.
  • Avanti Polar Lipids, LLC by Croda International Plc
  • BioNTech SE
  • Corden Pharma International GmbH
  • CureVac SE
  • Danaher Corporation
  • Entos Pharmaceuticals
  • Etherna Immunotherapies Nv
  • Evonik Industries AG
  • FUJIFILM Holdings Corporation
  • Generation Bio Co.
  • Genevant Sciences Corporation
  • GlaxoSmithKline PLC
  • GreenLight Biosciences, Inc.
  • Merck KGaA
  • METiS Pharmaceuticals
  • Moderna Inc.
  • Nitto Denko Corporation
  • Pfizer Inc.
  • Polymun Scientific Immunbiologische Forschung GmbH
  • RiboPro
  • Silence Therapeutics PLC
  • Translate Bio Inc by Sanofi S.A.
  • VBI Vaccines Inc.
  • Wacker Chemie AG

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 903.41 Million
Forecasted Market Value ( USD ) by 2030 $ 1190 Million
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Lipid Nanoparticle Raw Material Market by Product Type, Application, Distribution Channel, End-user - Global Forecast to 2030 - Product Image

Lipid Nanoparticle Raw Material Market by Product Type, Application, Distribution Channel, End-user - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Lipid Nanoparticle Market Size, Share & Trends Analysis Report by LNP (Liposomes, Nanostructured Lipid Carriers), Molecule (MRNA, SiRNA), Application, Indication, End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Lipid Nanoparticle Market Size, Share & Trends Analysis Report by LNP (Liposomes, Nanostructured Lipid Carriers), Molecule (MRNA, SiRNA), Application, Indication, End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Lipid Nanoparticle Raw Materials - Global Strategic Business Report - Product Image

Lipid Nanoparticle Raw Materials - Global Strategic Business Report

  • Report
  • 368 Pages
  • Global
From
Lipid Nanoparticle Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Lipid Nanoparticle, Type of Molecule Delivered, Company Size, Target Therapeutic Area, Type of End-user and Key Geographical Regions - Product Image

Lipid Nanoparticle Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Lipid Nanoparticle, Type of Molecule Delivered, Company Size, Target Therapeutic Area, Type of End-user and Key Geographical Regions

  • Report
  • 290 Pages
  • Global
From
Lipid Nanoparticles Market 2024-2028 - Product Image

Lipid Nanoparticles Market 2024-2028

  • Report
  • 207 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.